论文部分内容阅读
本文分析比较静脉溶栓治疗对老年急性心肌梗塞患者近期及远期预后的影响，２４例患者分为两组，溶栓组１２例，年龄６０～７７岁，静脉滴注尿激酶１００万Ｕ或链激酶１５０万Ｕ；对照组１２例，年龄６１～７９岁。全部患者均为男性。发现溶栓组近期冠脉再通率５８．３％，３０天内死亡１人；对照组无再通的临床征象，死亡２人。存活者随访观察３年，溶栓组左室射血分数较对照组高（５１．５８±７．６２％比４２．４１±１．４９％，Ｐ＜０．０５）。但梗塞后心绞痛、心律失常、再次心肌梗塞的发生率和病死率两组间无统计学意义的差别
This article analyzes the comparison of intravenous thrombolytic therapy in elderly patients with acute myocardial infarction in the short and long term prognosis, 24 patients were divided into two groups, thrombolytic group of 12 patients aged 60 to 77 years, intravenous infusion of urokinase 1 million U or Streptokinase 1.5 million U; control group of 12 patients, aged 61 to 79 years. All patients were male. The recent rate of coronary recanalization in the thrombolytic group was 58.3%. One patient died within 30 days. The control group had no clinical signs of recanalization and two died. Survivors were followed up for 3 years. The left ventricular ejection fraction in the thrombolysis group was higher than that in the control group (51.58 ± 7.62% vs. 42.41 ± 1.49%, P <0.05). However, there was no significant difference between the two groups in the incidence of post-infarction angina pectoris, arrhythmia, second myocardial infarction, and mortality